Rapport Therapeutics, Inc. Common Stock (RAPP) EPS is -$3.82
Rapport Therapeutics, Inc. Common Stock (RAPP) EPS is -$3.82. That figure is from Lician’s product cache for this healthcare name — not a placeholder and not copied across tickers.
Read the full RAPP research page for quote, filings, and the rest of the model. This satellite exists so “Rapport Therapeutics, Inc. Common Stock EPS” can rank with the actual number, then send you to /stock/rapp.